.

Program for Emerging Technologies in Immune Cell Therapies

Led by Catherine Bollard, MD, the Program for Emerging Technologies in Immune Cell Therapies (PETI) seeks to understand how we can co-opt the body's own immune system to combat cancer, infections, and disorders of immunity, for example graft-versus host disease (GvHD), autoimmunity and immune deficiency. The Program also focuses on developing cell therapy for regenerative medicine covering ischemic disorders, tissue damage, and wound healing. Our goal is to facilitate translational research, moving novel cell therapies from the bench to the clinic for a broad range of diseases from cancer and post-transplant complications to chronic inflammatory and infectious diseases and new applications of cell therapy for cardiac, neurological, and pulmonary diseases.

Faculty with interests in immune cell therapies:

give feedback
overlay-close-btn

Feedback

Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.